Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Cladribine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 18 Myelodysplastic Syndromes 7 Recurrence 4 Leukemia, Hairy Cell 4 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Sarcoma, Myeloid 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Monocytic, Acute 2 Targeted Therapy 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myasthenia Gravis 1 Leukemia, Prolymphocytic, T-Cell 1 Blast Crisis 1

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡